Stem cell treatment for painful poor blood flow in limbs
Part of Heart & circulation clinical trials.
This trial tests whether a stem cell product (Stempeucel®) is safe and effective for people with Buerger’s disease causing critical limb ischemia and foot ulcers. It may help improve healing and blood flow when other options may be limited.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old and can use birth control during the study if needed
- You have Buerger’s disease (diagnosed using the study’s criteria)
- You have at least one foot ulcer sized about 0.5 to 10 square centimeters
- Tests show poor blood flow: ABPI is 0.6 or less (or TBI is 0.5 or less if ABPI is high)
- You can understand the study and agree to sign consent and return for follow-up visits
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a stem cell product (Stempeucel®) can improve healing and safety for people with critical limb ischemia caused by peripheral artery disease. It is for patients who cannot have (or have already tried) procedures to reopen blocked leg arteries and who have a leg ulcer and low blood-flow measurements.
This study tests whether stem cells taken from donated fat tissue are safe to inject into people with severe leg circulation problems (critical limb ischemia). It aims to see if the treatment is well tolerated and may help improve blood flow and reduce pain.
This trial tests a new minimally invasive procedure (placing a small stent) to improve blood flow to a severely threatened foot or lower leg. It may help people whose ulcers or gangrene are not treatable with standard bypass or other surgeries.
This trial tests a cell-based treatment for leg ulcers that haven't healed with standard care in people with severe peripheral artery disease. The goal is to see if this therapy can help wounds heal and improve blood flow.
This trial studies a new treatment using stem cell-derived exosomes (tiny particles from stem cells) applied to the foot to see if it can help heal diabetic foot wounds. It aims to improve healing and reduce complications for people with diabetes who have foot issues.
This Phase 1 study tests whether injected stem cells can help wounds heal faster or better. It focuses on people with specific wound types and sizes, and checks safety and wound healing over weekly visits.
Hear when a new Critical Limb Ischemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.